Your trusted source for investing success

Tag: China

First Global Provides Update on Fintech Remittance Business Model

First Global Data (TSXV:FGD) has stated it would like to elaborate on its recent deal with LianLian Pay.

As quoted in the press release:
We believe this is the world’s first social messaging multi integrated remittance platform whereby SOCIAL converges on FINTECH in the flow of cross border money.

Marketing: LianLian is committing

Almonty Industries Reached Agreement with Global Tungsten & Powders

Almonty Industries Inc. (TSX-V:AII) (“Almonty”) announces that it has reached agreement with Global Tungsten & Powders Corp. (“GTP”) on the termination of a loan agreement pursuant to which Almonty was indebted to GTP in the amount of USD$7,043,128 (CAD$9,415,183) of principal and accrued interest.

As quoted in the press release:
Lewis Black,

Why Invest in Cybersecurity?

Why Invest in Cybersecurity?

As more people use the Internet, the cybersecurity market is becoming increasingly instrumental. Here’s a brief overview of why cybersecurity investing is worth looking into.

Ceylon Graphite Purchases Drill Rig

Ceylon Graphite Corp. (“Ceylon”) (TSX VENTURE:CYL)(OTC:CYLYF)(FRANKFURT:CCY) announces that Sarcon Development (PVT) Ltd (“Sarcon”) its wholly owned subsidiary has purchased a HXY-2T type Core Drilling Rig from the H.H. Drill-Tech Drilling Machinery Co Ltd based in Lianyungang, Jiangsu Province, China. It is anticipated the drill will arrive in Sri Lanka by

Marten Falls and KWG to Propose Ring of Fire Mining Partnership

The Marten Falls First Nation has undertaken with KWG Resources Inc. (CSE:KWG)(CSE:KWG.CN)(FRANKFURT:KW6) (“KWG” or the “Company”) to work towards establishing the principal terms of an equal partnership for the mining of chromite in the Ring of Fire.

As quoted in the press release:
The parties envisage large-volume underground mining operations for the

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network